Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases.
Kuo, C.J., Guo, R.T., Lu, I.L., Liu, H.G., Wu, S.Y., Ko, T.P., Wang, A.H., Liang, P.H.(2008) J Biomed Biotechnol 2008: 841312-841312
- PubMed: 18382620 
- DOI: 10.1155/2008/841312
- Primary Citation of Related Structures:  
2D2R - PubMed Abstract: 
Helicobacter pylori colonizes the human gastric epithelium and causes diseases such as gastritis, peptic ulcers, and stomach cancer. Undecaprenyl pyrophosphate synthase (UPPS), which catalyzes consecutive condensation reactions of farnesyl pyrophosphate with eight isopentenyl pyrophosphate to form lipid carrier for bacterial peptidoglycan biosynthesis, represents a potential target for developing new antibiotics ...